Cargando…
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells
BACKGROUND: The resistance to PD-1/PD-L1 inhibitors for the treatment of melanoma have prompted investigators to implement novel clinical trials which combine immunotherapy with different treatment modalities. Moreover is also important to investigate the mechanisms which regulate the dynamic expres...
Autores principales: | Botti, Gerardo, Fratangelo, Federica, Cerrone, Margherita, Liguori, Giuseppina, Cantile, Monica, Anniciello, Anna Maria, Scala, Stefania, D’Alterio, Crescenzo, Trimarco, Chiara, Ianaro, Angela, Cirino, Giuseppe, Caracò, Corrado, Colombino, Maria, Palmieri, Giuseppe, Pepe, Stefano, Ascierto, Paolo Antonio, Sabbatino, Francesco, Scognamiglio, Giosuè |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324267/ https://www.ncbi.nlm.nih.gov/pubmed/28231855 http://dx.doi.org/10.1186/s12967-017-1150-7 |
Ejemplares similares
-
Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survival
por: Panza, Elisabetta, et al.
Publicado: (2016) -
Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types
por: Scognamiglio, Giosuè, et al.
Publicado: (2016) -
Increased HOX C13 expression in metastatic melanoma progression
por: Cantile, Monica, et al.
Publicado: (2012) -
The Ratio of GrzB(+) − FoxP3(+) over CD3(+) T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic Melanoma
por: Scognamiglio, Giosuè, et al.
Publicado: (2021) -
LncRNA HOTAIR in Tumor Microenvironment: What Role?
por: Botti, Gerardo, et al.
Publicado: (2019)